The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Baines, C. P., Kaiser, R. A., Purcell, N. H., Blair, N. S., Osinska, H., Hambleton, M. A., Brunskill, E. W., Sayen, M. R., Gottlieb, R. A., Dorn, G. W., et al. (2005) · Nature · doi:10.1038/nature03434 · Cited by 2,280
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts
Murry, C. E., Soonpaa, M. H., Reinecke, H., Nakajima, H., Nakajima, H. O., Rubart, M., Pasumarthi, K. B. S., Ismail Virag, J., Bartelmez, S. H., Poppa, V., et al. (2004) · Nature · doi:10.1038/nature02446 · Cited by 2,154
Self-citationFeeder-free growth of undifferentiated human embryonic stem cells
Xu, C., Inokuma, M. S., Denham, J., Golds, K., Kundu, P., Gold, J. D., & Carpenter, M. K. (2001) · Nature Biotechnology · doi:10.1038/nbt1001-971 · Cited by 1,870
Self-citationKehat, I., Kenyagin‐Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A., Livne, E., Binah, O., Itskovitz‐Eldor, J., & Gepstein, L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12131 · Cited by 1,814
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R. E., Ingwall, J. S., et al. (2005) · Nature Medicine · doi:10.1038/nm0405-367 · Cited by 1,677 · cited 1×
“There is evidence that transplanted cells produce paracrine factors that enhance survival of host cardiomyocytes postinfarctio”
BackgroundNakagawa, T., Shimizu, S., Watanabe, T., Yamaguchi, O., Otsu, K., Yamagata, H., Inohara, H., Kubo, T., & Tsujimoto, Y. (2005) · Nature · doi:10.1038/nature03317 · Cited by 1,635 · cited 1×
“, cyclosporine A to attenuate cyclophilin D–dependent mitochondrial pathway”
BackgroundKinnaird, T., Stabile, E., Burnett, M. S., Lee, C. W., Barr, S., Fuchs, S., & Epstein, S. E. (2004) · Circulation Research · doi:10.1161/01.res.0000118601.37875.ac · Cited by 1,415 · cited 1×
“Paracrine factors may also enhance angiogenesis, improve the extracellular matrix or modulate the immune/inflammatory respons”
Background
Cited by
Items 101–143 of 143
Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications
Yoshida, Y., & Yamanaka, S. (2017) · Circulation Research · doi:10.1161/circresaha.117.311080 · Cited by 264
Goldfracht, I., Protze, S., Shiti, A., Setter, N., Gruber, A., Shaheen, N., Nartiss, Y., Keller, G., & Gepstein, L. (2020) · Nature Communications · doi:10.1038/s41467-019-13868-x · Cited by 263
Li, T.-S., Cheng, K., Lee, S.-T., Matsushita, S., Davis, D., Malliaras, K., Zhang, Y., Matsushita, N., Smith, R. R., & Marbán, E. (2010) · Stem Cells · doi:10.1002/stem.532 · Cited by 263
Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model
Riegler, J., Tiburcy, M., Ebert, A., Tzatzalos, E., Raaz, U., Abilez, O. J., Shen, Q., Kooreman, N. G., Neofytou, E., Chen, V. C., et al. (2015) · Circulation Research · doi:10.1161/circresaha.115.306985 · Cited by 258
Self-citationMaturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues
Feric, N. T., & Radisic, M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.04.019 · Cited by 247
Garbern, J. C., Minami, E., Stayton, P. S., & Murry, C. E. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.075 · Cited by 252
Self-citationZhu, W.-Z., Xie, Y., Moyes, K. W., Gold, J. D., Askari, B., & Laflamme, M. A. (2010) · Circulation Research · doi:10.1161/circresaha.110.223917 · Cited by 228
Self-citationBiomaterials for the Treatment of Myocardial Infarction
Rane, A. A., & Christman, K. L. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.11.001 · Cited by 226
Teratomas from pluripotent stem cells: A clinical hurdle
Fong, C., Gauthaman, K., & Bongso, A. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22775 · Cited by 222
Niebruegge, S., Bauwens, C. L., Peerani, R., Thavandiran, N., Masse, S., Sevaptisidis, E., Nanthakumar, K., Woodhouse, K., Husain, M., Kumacheva, E., et al. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22065 · Cited by 222
“…al., 2002), coculture (Bin et al., 2006; Mummery et al., 2003; Passier et al., 2005) or serum-free cytokine induction (Kattman et al., 2006, 2007; Laflamme et al., 2007; Li et al., 2005; Ludwig et al., 2006; McDevitt et al., 2005; Passier et al., 2005; Xu et al., 2006b; Yang et al., 2008; Zhang…”
BackgroundBargehr, J., Ong, L. P., Colzani, M., Davaapil, H., Hofsteen, P., Bhandari, S., Gambardella, L., Le Novère, N., Iyer, D., Sampaziotis, F., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0197-9 · Cited by 195
Self-citationStem Cell Therapy for Vascular Regeneration: Adult, Embryonic, and Induced Pluripotent Stem Cells
Leeper, N. J., Hunter, A. L., & Cooke, J. P. (2010) · Circulation · doi:10.1161/circulationaha.109.881441 · Cited by 195
Kensah, G., Roa Lara, A., Dahlmann, J., Zweigerdt, R., Schwanke, K., Hegermann, J., Skvorc, D., Gawol, A., Azizian, A., Wagner, S., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs349 · Cited by 193
In vitro cardiac tissue models: Current status and future prospects
Mathur, A., Ma, Z., Loskill, P., Jeeawoody, S., & Healy, K. E. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.011 · Cited by 187
“Nowadays, monolayer differentiation, which involves simple, serum-free, and scalable protocols, has largely replaced embryoid body formation [32, 33].”
BackgroundInduced pluripotent stem cells: at the heart of cardiovascular precision medicine
Chen, I. Y., Matsa, E., & Wu, J. C. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.36 · Cited by 191
Protze, S. I., Lee, J. H., & Keller, G. M. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.07.010 · Cited by 162
Tzatzalos, E., Abilez, O. J., Shukla, P., & Wu, J. C. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.010 · Cited by 162
Später, D., Hansson, E. M., Zangi, L., & Chien, K. R. (2014) · Development · doi:10.1242/dev.091538 · Cited by 143
Brafman, D. A., Phung, C., Kumar, N., & Willert, K. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.138 · Cited by 126
Chen, A., Lieu, D. K., Freschauf, L., Lew, V., Sharma, H., Wang, J., Nguyen, D., Karakikes, I., Hajjar, R. J., Gopinathan, A., et al. (2011) · Advanced Materials · doi:10.1002/adma.201103463 · Cited by 122
Liu, J., Lieu, D. K., Siu, C. W., Fu, J.-D., Tse, H.-F., & Li, R. A. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00060.2009 · Cited by 109
Matsa, E., Ahrens, J. H., & Wu, J. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00036.2015 · Cited by 105
“Finally, the labor intensive process of embryoid body formation has been replaced by hiPSC differentiation in monolayer (145) or suspension cultures (37) that generate over 90% pure CM populations, and are amenable to automation and scale-up of 1.”
MethodDevelopment of a Biological Ventricular Assist Device: Preliminary Data From a Small Animal Model
Yildirim, Y., Naito, H., Didié, M., Karikkineth, B. C., Biermann, D., Eschenhagen, T., & Zimmermann, W.-H. (2007) · Circulation · doi:10.1161/circulationaha.106.679688 · Cited by 100
Concise Review: Kidney Stem/Progenitor Cells: Differentiate, Sort Out, or Reprogram?
Pleniceanu, O., Harari-Steinberg, O., & Dekel, B. (2010) · Stem Cells · doi:10.1002/stem.486 · Cited by 100
Cardiac Tissues From Stem Cells: New Routes to Maturation and Cardiac Regeneration
Campostrini, G., Windt, L. M., van Meer, B. J., Bellin, M., & Mummery, C. L. (2021) · Circulation Research · doi:10.1161/circresaha.121.318183 · Cited by 96
Guan, X., Xu, W., Zhang, H., Wang, Q., Yu, J., Zhang, R., Chen, Y., Xia, Y., Wang, J., & Wang, D. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01602-0 · Cited by 91
Self-citationParrotta, E. I., Lucchino, V., Scaramuzzino, L., Scalise, S., & Cuda, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124354 · Cited by 88
“Serum was later replaced by cytokines and growth factors known to be involved in heart development such as Wnt proteins [38], bone morphogenetic proteins (BMPs) and activin A [31,39], and Notch signals [40], together with their corresponding inhibitors [41,42].”
BackgroundKeung, W., Boheler, K. R., & Li, R. A. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt406 · Cited by 87
Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery
Braam, S. R., Passier, R., & Mummery, C. L. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.07.001 · Cited by 86
Engineered cardiac organoid chambers: toward a functional biological model ventricle
Lee, E. J., Kim, D. E., Azeloglu, E. U., & Costa, K. D. (2008) · Tissue Engineering Part A · doi:10.1089/tea.2007.0351 · Cited by 84
Hamad, S., Derichsweiler, D., Papadopoulos, S., Nguemo, F., Šarić, T., Sachinidis, A., Brockmeier, K., Hescheler, J., Boukens, B. J., & Pfannkuche, K. (2019) · Theranostics · doi:10.7150/thno.32058 · Cited by 83
Devalla, H. D., & Passier, R. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aah5457 · Cited by 75
Hinderer, S., Brauchle, E., & Schenke‐Layland, K. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201400762 · Cited by 68
Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes
Giacomelli, E., Mummery, C. L., & Bellin, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2546-5 · Cited by 60
Dunn, K. K., & Palecek, S. P. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00110 · Cited by 41
Activin-A and Bmp4 Levels Modulate Cell Type Specification during CHIR-Induced Cardiomyogenesis
Kim, M.-S., Horst, A., Blinka, S., Stamm, K., Mahnke, D., Schuman, J., Gundry, R., Tomita-Mitchell, A., & Lough, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118670 · Cited by 38
“This result may be reconciled with cardiomyogenic protocols that employ high levels of Activin-A during Day 0–1 [13,28] by considering that DE cells that are directly induced by this treatment may subsequently induce cardiomyogenesis in indirect fashion [27,29,30], and/or that the effects of Activin-A are context-depe…”
BackgroundMethodResultInfluentialChen, G., Li, S., Karakikes, I., Ren, L., Zi-Ying Chow, M., Chopra, A., Keung, W., Yan, B., Chan, C. W. Y., Costa, K. D., et al. (2015) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.114.002049 · Cited by 38
Comparison of Cardiomyogenic Potential among Human ESC and iPSC Lines
Sepac, A., Si-Tayeb, K., Sedlic, F., Barrett, S., Canfield, S., Duncan, S. A., Bosnjak, Z. J., & Lough, J. W. (2012) · Cell Transplantation · doi:10.3727/096368912x653165 · Cited by 36
Chung, C., Pruitt, B. L., & Heilshorn, S. C. (2013) · Biomaterials Science · doi:10.1039/c3bm60139k · Cited by 34
Modeling motor neuron disease: the matter of time
Arbab, M., Baars, S., & Geijsen, N. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.07.008 · Cited by 33
Yan, Y., Bejoy, J., Xia, J., Griffin, K., Guan, J., & Li, Y. (2019) · Scientific Reports · doi:10.1038/s41598-018-37686-1 · Cited by 27
Liu, S., Fang, C., Zhong, C., Li, J., & Xiao, Q. (2023) · Cell Biology and Toxicology · doi:10.1007/s10565-023-09835-4 · Cited by 22
“Most available CM differentiation protocols such as the Percoll density gradient procedure(Laflamme et al. 2007; Xu et al. 2002), cardiac specific promoters used for genetic manipulation(Anderson et al. 2007; Bizy et al. 2013; Elliott et al. 2011), mitochondrial dyes applied for cell…”
Method(2012) · Journal of Stem Cells and Regenerative Medicine · doi:10.46582/jsrm.0803013 · Cited by 13
“Although the commonly used embryoid body (EB) formation protocol for hESC cardiac differentiation generates only 8% cardiomyocytes,([1]) recent studies have shown that Activin A/BMP4 signaling induces mesoderm with enhanced numbers of cardiomyocytes (30%).([2-5]) Most recently, Kattman et al.”
Metadata
- Authors
- Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., O'Sullivan, C., Collins, L., Chen, Y., Minami, E., Gill, E. A., Ueno, S., Yuan, C., Gold, J., & Murry, C. E.
- Venue
- Nature Biotechnology
- Published
- 2007-08-26
- Volume
- 25
- Issue
- 9
- Pages
- 1015-1024
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2169859308
- Cited by
- 2,206
- References
- 70
- FWCI
- 49.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.